论文部分内容阅读
65％的泛影葡胺使用于CT增强扫描,药理作用使显影清晰。但在药物注入体内时,个别患者可能会发生过敏,出现诸如恶心、皮肤过敏、喉痉挛、血压下降、休克等反应,严重者可危及生命。笔者就一患者静脉滴注65％泛影葡胺6小时后出现过敏反应的病例报告如下: 患者,女性,30岁,护士。于1996年1月6日上午8时许,于门诊诊断为肺部感染而至我科行CT检查。CT平扫显示“右肺中叶大片阴影”,建议增强
65% of the diatrizoate meglumine used in CT enhanced scanning, pharmacological effects make the development clear. However, when the drug is injected into the body, individual patients may develop allergies, such as nausea, skin allergies, laryngospasm, blood pressure, shock and other reactions, serious cases can be life-threatening. The author on a patient intravenous infusion of 65% diatrizoate 6 hours after the occurrence of allergic reaction case reports are as follows: Patients, women, 30 years old, nurses. At 6 o’clock on the January 6, 1996, at the outpatient diagnosis of lung infection and CT scan to our line. CT scan shows “large shadow in the middle of the right lung”, the proposed enhancement